Clinical observation of paraplatin used within the cavity for malignant serous cavity effusion
- VernacularTitle:伯尔定腔内给药治疗恶性浆膜腔积液的临床观察
- Author:
Jun QIAN
;
Shukui QIN
;
Xiufeng LIU
;
Liuqing YANG
;
Zeming HE
;
Zhijian SHAO
- Publication Type:Journal Article
- Keywords:
Paraplatin;
Malignant pleural effusion;
Malignant peritoneal effusion;
Malignant pericardial effusion
- From:
Cancer Research and Clinic
2001;0(02):-
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the efficacy and toxicity of paraplatin used within the cavity for the treatment of malignant serous cavity effusion. Methods Puncturing with catheter of centre vein and permanent catheter, withdrawing proper volume of malignant effusion, 150 ～ 450 mg paraplatin was infused into the serous cavity each time for once or twice a week till the effusion was disappeared or there was no change. Results 76 cases were evaluable for response and toxicity. There were 21 patients with CR, 33 patients with PR and 22 patients with NR. The ORR was 71 %. Among them, the RR in malignant pleural effusion group was 79 %(27/34), 50 %(13/26) in the peritoneal effusion and 87 %(14/16) in the pericardial effusion. Only I ~ II degree bone marrow suppression was observed. Conclusions Paraplatin used within the cavity is more effective and safe for treating malignant serous cavity effusion.
